Thyroid Disorders in Childhood and Adolescence

Pediatric Endocrinology

Volumn , Issue , 2008, Pages 227-253

  Fisher, Delbert A ^a   Grueters, Annette ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882460808     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-141604090-3.50012-0     Document Type: Chapter

References (162)

1. Fisher DA, Grueters A Thyroid disorders. Principles and practice of medical genetics 2007, 1932-1950. Churchill Livingstone, New York. Fifth edition. D.L. Rimoin, B.R. Korf, R.E. Pyeritz, J.M. Connor (Eds.).
2. Fisher DA, DeLange FM Thyroid hormone and iodine requirements in man during brain development. Iodine in pregnancy 1998, 1-33. Oxford University Press, New Delhi. J.B. Stanbury, F. Delange, J.T. Dunn, C.S. Pandav (Eds.).
3. Carrasco N Thyroid iodine transport. The thyroid: A fundamental and clinical text 2005, 37-52. Lippincott Williams & Wilkins, Philadelphia. Ninth edition. L.E. Braverman, R.D. Utiger (Eds.).
4. Kim P Thyroid hormone formation. Endocrinology 2006, 1823-1836. Elsevier-Saunders, Philadelphia. Fifth edition. L.J. DeGroot, J.L. Jameson (Eds.).
5. Arvin P, DiJeso B Thyroglobulin structure, function and biosynthesis. The thyroid: A fundamental and clinical text 2005, 77-95. Lippincott Williams & Wilkins, Philadelphia. Ninth edition. L.E. Braverman, R.D. Utiger (Eds.).
6. De Nayer P, Cornette C, Vanderschueren M, et al. Serum thyroglobulin levels in preterm neonates. Clin Endocrinol 1984, 21:149.
7. Pezzino V, Vigneri R, Squattito S, Filetti S, Camus M, Palosa P Increased serum thyroglobulin levels in patients with nontoxic goiter. J Clin Endocrinol Metab 1978, 46:653.
8. Sava L, Tomaselli L, Runello F, Belfiore A, Vigneri R Serum thyroglobulin levels are elevated in newborns from iodine deficient areas. J Clin Endocrinol Metab 1986, 62:429.
9. Kopp P Thyroid hormone synthesis. The thyroid: A fundamental and clinical text 2005, 52-76. Lippincott Williams & Wilkins, Philadelphia. Ninth edition. L.E. Braverman, R.D. Utiger (Eds.).
10. Hollenberg AN Regulation of thyrotropin secretion. The thyroid: A fundamental and clinical text 2005, 197-213. Lippincott Williams & Wilkins, Philadelphia. Ninth edition. L.E. Braverman, R.D. Utiger (Eds.).
11. Szkudlinski MW, Kazlaukaite R, Weintraub BD Thyroid stimulating hormone and regulation of the thyroid axis. The thyroid: A fundamental and clinical text 2005, 1803-1822. Lippincott Williams & Wilkins, Philadelphia. Ninth edition. L.J. DeGroot, J.L. Jameson (Eds.).
12. Benvenga S Thyroid hormone transport proteins and the physiology of hormone binding. The thyroid: A fundamental and clinical text 2005, 97-108. Lippincott Williams & Wilkins, Philadelphia. Ninth edition. L.E. Braverman, R.D. Utiger (Eds.).
13. Bianco AC, Larsen PR Intracellular pathway of iodothyronine metabolism. The thyroid: A fundamental and clinical text 2005, 109-133. Lippincott Williams & Wilkins, Philadelphia. Ninth edition. L.E. Braverman, R.D. Utiger (Eds.).
14. Wu SY, Green WL, Huang WS, et al. Alternate pathways of thyroid hormone metabolism. Thyroid 2005, 15:943.
15. Hollenberg AN, Jameson JL Mechanisms of thyroid hormone action. Endocrinology 2006, 1873-1897. Elsevier-Saunders, Philadelphia. Fifth edition. L.J. DeGroot, J.L. Jameson (Eds.).
16. Yen PM Genomic and nongenomic actions of thyroid hormones. The thyroid: A fundamental and clinical text 2005, 135-150. Lippincott Williams & Wilkins, Philadelphia. Ninth edition. L.E. Braverman, R.D. Utiger (Eds.).
17. Weiss RE, Murata Y, Cua K, et al. Thyroid hormone action on liver, heart, and energy expenditure in thyroid hormone receptor b-deficient mice. Endocrinology 1998, 139:4945.
18. Göthe S, Wang Z, Ng L, et al. Mice devoid of all known thyroid hormone receptors are viable but exhibit disorders of the pituitary-thyroid axis, growth, and bone maturation. Genes & Devel 1999, 13:1329.
19. Jansen J, Friesema ECH, Milici C, Visser J Thyroid hormone transporters in health and disease. Thyroid 2005, 1:757.
20. Goglia F, Moreno M, Lanni A Action of thyroid hormones at the cellular level: The mitochondrial target. FEBS Letters 1999, 452:115.
21. Ponchon G, Beckers C, De Visscher M Iodine kinetic studies in newborns and infants. J Clin Endocrinol Metab 1966, 21:1392.
22. Oliner L, Kohlenbrener RM, Fields T, Kunstadter RH Thyroid function studies in children: Normal values for thyroidal I131 uptake and PBI131 levels up to the age of 18. J Clin Endocrinol Metab 1957, 17:67.
23. Beckers C, Malvaux C, De Visscher M Quantitative aspects of the secretion and degradation of thyroid hormones during adolescence. J Clin Endocrinol Metab 1966, 26:202.
24. Fisher DA, Sack J, Oddie TH, et al. Serum T4, TBG, T3 uptake, T3, reverse T3 and TSH concentrations in children 1 to 15 years of age. J Clin Endocrinol Metab 1977, 45:191.
25. Nelson JC, Clark SJ, Borut DL, et al. Age related changes in serum free thyroxine during childhood and adolescence. J Pediatr 1993, 123:899.
26. Zurakowski D, DiCanzio J, Majzoub JA Pediatric reference intervals for serum thyroxine, triiodothyronine thyrotropin, and free thyroxine. Clin Chem 1999, 45:1087.
27. Sapin R, Schlienger JL, Goichot B, et al. Evaluation of elecsys free triiodothyronine assay: Relevance of age related reference ranges. Clin Biochem 1998, 31:399.
28. Meier CA, Burger AG Effects of drugs and other substances on thyroid hormone synthesis and metabolism. The thyroid: A fundamental and clinical text 2005, 229-246. Lippincott Williams & Wilkins, Philadelphia. Ninth edition. L.E. Braverman, R.D. Utiger (Eds.).
29. Gaitan E Environmental goitrogens. The thyroid gland: A practical clinical treatise 1986, 263-280. Yearbook, Chicago. L. Van Middlesworth, J.R. Givens (Eds.).
30. Shabana W, Delange F, Freson M, et al. Prevalence of thyroid hemiagensis: Ultrasound screening in normal children. Eur J Pediatr 2000, 159:456.
31. Maiorana R, Carta A, Floriddia G, et al. Thyroid hemiagenesis: Prevalence in normal children and effect on thyroid function. J Clin Endocrinol Metab 2003, 88:1535.
32. Weetman A Chronic autoimmune thyroiditis. The thyroid: A fundamental and clinical text 2005, 701-713. Lippincott Williams & Wilkins, Philadelphia. Ninth edition. L.E. Braverman, R.D. Utiger (Eds.).
33. Amino N, Hidaka Y Chronic (Hashimoto's) thyroiditis. Endocrinology 2006, 2055-2067. Elsevier-Saunders, Philadelphia. Fifth edition. L.J. DeGroot, J.L. Jameson (Eds.).
34. Pearce EN, Farwell AP, Braverman LE Thyroiditis. New Engl J Med 2003, 348:2646.
35. Inoue M, Taketani N, Sato T, Nakajima H High incidence of chronic lymphocytic thyroiditis in apparently healthy school children: Epidemiological and clinical study. Endocrinol Jpn 1975, 22:483.
36. Rallison M, Dobyns BM, Keating FR, et al. Chronic lymphyocytic thyroiditis in children. J Pediatr 1975, 86:675.
37. Zois C, Stavrou I, Kalogera C, et al. The high prevalence of autoimmune thyroiditis in schoolchildren after elimination of iodine deficiency in Northeastern Greece. Thyroid 2003, 13:485.
38. Gordin A, Lamberg BA Spontaneous hypothyroidism in symptomless autoimmune thyroiditis: A long term follow-up study. Clin Endocrinol 1981, 15:537.
39. Hayashi Y, Tamai H, Fukata S, et al. A long term clinical, immunological and histological follow-up of patients with goitrous chronic lymphocytic thyroiditis. J Clin Endocrinol Metab 1985, 62:1172.
40. Roth C, Scortea M, Stubbe P, et al. Autoimmune thyroiditis in childhood: Epidemiology, clinical and laboratory findings in 61 patients. Exp Clin Endocrinol Diabetes 1997, 105(4):66-69.
41. Bright GM, Blizzard RM, Kaiser DL, Clarke WL Organ specific autoantibodies in children with common endocrine diseases. J Pediatr 1982, 100:8.
42. Girotra M, Bluestone JA, Herold JC Immunologic mechanisms causing autoimmune endocrine disease. Endocrinology 2006, 769-797. Elsevier-Saunders, Philadelphia. Fifth edition. L.J. DeGroot, J.L. Jameson (Eds.).
43. Maclaren NK Autoimmune polyglandular syndromes. Endocrinology 2006, 819-835. Elsevier-Saunders, Philadelphia. Fifth edition. L.J. DeGroot, J.L. Jameson (Eds.).
44. Holl RW, Böhm B, Loos U, et al. Thyroid autoimmunity in children and adolescents with type 1 diabetes mellitus. Horm Res 1999, 52:113.
45. Jordan SG, Buckingham B, Sakai R, Olson D Studies of immune complex glomerulonephritis mediated by human thyroglobulin. N Engl J Med 1981, 304:1212.
46. Hymes K, Blum M, Lackner H, Karpatkin S Easy bruising thrombocytopenia, and elevated platelet immunoglobulin G in Graves' disease and Hashimoto's thyroiditis. Ann Intern Med 1981, 94:27.
47. Valentino R, Savastano S, Tommaselli AP, et al. Prevalence of coeliac disease in patients with thyroid autoimmunity. Horm Res 1999, 51:124.
48. Pearce SHS, Kendall-Taylor P Genetic factors in thyroid disease. The thyroid: A fundamental and clinical text 2005, 407-421. Lippincott Williams & Wilkins, Philadelphia. Ninth edition. L.E. Braverman, R.D. Utiger (Eds.).
49. Christiakov DA, Turakulov RI CTLA-4 and its role in autoimmune thyroid disease. J Mol Endocrinol 2003, 31:21.
50. Rose SR Isolated central hypothyroidism in short stature. Pediatr Res 1995, 38:967.
51. Gruneiro-Papendieck L, Chiesa A, Martinez A, et al. Nocturnal TSH surge and TRH test response in the evaluation of thyroid axis in hypothalamic pituitary disorders in childhood. Horm Res 1998, 50:252.
52. van Tijn DA, de Vijlder JJM, Verbeeten B, et al. Neonatal detection of congenital hypothyroidism of central origin. J Clin Endocrinol Metab 2005, 90:3350.
53. Cutler AT, Benezra-Obeiter R, Brink SJ Thyroid function in young children with Down Syndrome. Am J Dis Child 1986, 140:479.
54. Sharav T, Landau H, Zadik Z, Cinarson TR Age related patterns of thyroid stimulating hormone response to thyrotropin-releasing hormone stimulation in Down Syndrome. Am J Dis Child 1991, 145:172.
55. Ivarsson SA, Ericsson VB, Gustafsson J, et al. The impact of thyroid autoimmunity in children and adolescents with Down syndrome. Acta Paediatr 1997, 86:105.
56. Pai GS, Leach DC, Weiss L, et al. Thyroid anormalities in 20 children with Turner syndrome. J Pediatr 1977, 91:267.
57. van Trotsenburg P, Vulsma T, Rutgers van Rozenburg-Marres S, et al. The effect of thyroxine treatment started in the neonatal period on development and growth of two-year old Down Syndrome children: A randomized clinical trial. J Clin Endocrinol Metab 2005, 90:3304.
58. Lucky AW, Howley PM, Megylesi J, et al. Endocrine studies in cystinosis: Compensated primary hypothyroidism. J Pediatr 1977, 91:204.
59. Van Vliet G Hypothyroidism in infants, children and adolescents: Acquired hypothyroidism. The thyroid: A fundamental and clinical text 2005, 1041-1047. Lippincott Williams and Wilkins, Philadelphia. Ninth edition. L.E. Braverman, R.D. Utiger (Eds.).
60. Watenburg N, Greenstein D, Levine A Encephalopathy associated with Hashimoto thyroiditis: Pediatric perspective. Child Neurol 2006, 21:01.
61. Van Wyk JJ, Grumbach MM Syndrome of precocious menstruation and galacorrhea in juvenile hypothyroidism: An example of hormonal overlap in pituitary feedback. J Pediatr 1960, 57:416.
62. Hemady ZS, Siler-Khodr TM, Najjar S Precocious puberty in juvenile hypothyrodism. Pediatrics 1978, 92:55.
63. Chattopadhyay A, Kumar V, Marulaiah M Polycystic ovaries, precocious puberty and acquired hypothyroidism: The Van Wyk and Grumbach syndrome. J Ped Surg 2003, 38:1390.
64. Anasti JN, Flack MR, Frochlich J, et al. A potential novel mechanism for precocious puberty in juvenile hypothyroidism. J Clin Endocrinol Metab 1995, 80:276.
65. Rodien P, Breson C, Sanson L, et al. Familial gestational hyperthyroidism caused by a mutant thyrotropin receptor hypersensitive to human chorionic gonadotropin. N Engl J Med 1998, 17:339.
66. Montanelli M, Delbaere A, Di Carlo C, et al. A mutation in the follicle-stimulating hormone receptor as a cause of familial spontaneous ovarian hyperstimulation syndrome. J Clin Endocrinol Metab 2004, 89:1255.
67. Abbassi V, Aldige C Evaluation of sodium L-thyroxine (T4) requirement in replacement therapy of hypothyroidism. J Pediatr 1977, 90:298.
68. Rezvani IR, DiGeorge AM Reassessment of the daily dose of oral thyroxine for replacement therapy in hypothyroid children. J Pediatr 1977, 90:291.
69. Niimi H, Sasaki N, Inomota H, Nakajima H Evaluation of L-thyroxine requirement in treatment of congenital hypothyroidism. Endocrinol Jpn 1980, 27:733.
70. DeGroot LJ Nonthyroidal illness syndrome. Endocrinology 2006, 2101-2112. Elsevier-Saunders, Philadelphia. Fifth edition. L.J. DeGroot, J.L. Jameson (Eds.).
71. Wiersinga WM Nonthyroidal illness. The thyroid: A fundamental and clinical text 2005, 247-263. Lippincott Williams & Wilkins, Philadelphia. Ninth edition. L.E. Braverman, R.D. Utiger (Eds.).
72. Peeters RP, Kester MHA, Wouters PJ, et al. Increased thyroxine sulfate levels in critically ill patients as a result of adecreased hepatic type 1 deiodinase level. J Clin Endocrinol Metab 2005, 90:6460.
73. Yu J, Koenig RJ Induction of type 1 iodothyronine deiodinase to prevent the nonthyroidal illness syndrome in mice. Endocrinology 2006, 147:3580.
74. Peeters RP, van der Geyten S, Wouters PJ, et al. Tissue thyroid hormone levels in critical illness. J Clin Endocrinol Metab 2005, 90:6498.
75. DeGroot LJ Dangerous dogmas in medicine: The non- thyroidal illness syndrome. J Clin Endocrinol Metab 1999, 84:151.
76. Delange FM, Dunn JT Iodine deficiency. The thyroid: A fundamental and clinical text 2005, 264-288. Lippincott Williams & Wilkins, Philadelphia. Ninth edition. L.E. Braverman, R.D. Utiger (Eds.).
77. Fenzi GF, Giusti LF, Aghini-Lombardi F, et al. Neuropsychological assessment in schoolchildren from an area of moderate iodine deficiency. J Endocrinol Invest 1990, 13:427.
78. Vermiglio F, Sidoti M, Finocchiaro MD, et al. Defective neuromotor and cognitive ability in iodine-deficient schoolchildren of an endemic goiter region in Sicily. J Clin Endocrinol Metab 1990, 70:379.
79. Huang SA, Tu HM, Harney JW, et al. Severe hypothyroidism caused by a type 3 iodothyronine deiodinase in infantile hemangiomas. N Engl J Med 2000, 343:185.
80. Gaven A, Aygun C, Ince H, et al. Severe hypothyroidism caused by hepatic hemangioendothelioma in an infant of a diabetic mother. Horm Res 2005, 63:86.
81. Ruppe MD, Huang SA, Jan de Beur SM Consumptive hypothyroidism caused by paraneoplastic production of type 3 iodothyronine deiodinase. Thyroid 2005, 15:1369.
82. Bayer Y, Neumann S, Meyer B, et al. Genome-wide linkage analysis reveals evidence for four new susceptibility loci for familial euthyroid goiter. J Clin Endocrinol Metab 2004, 89:4044.
83. Hermus Ad R, Huysmans DA Pathogenesis of nontoxic diffuse and nodular goiter and clinical manifestations and treatment of nontoxic diffuse and nodular goiter. The thyroid: A fundamental and clinical text 2005, 873-885. Lippincott Williams & Wilkins, Philadelphia, . Ninth edition. L.E. Braverman, R.D. Utiger (Eds.).
84. Drexhage HA, Botazzo GF, Doniach D, et al. Evidence for thyroid growth stimulating immunoglobulins in some goitrous thyroid diseases. Lancet 1980, 2:287.
85. Fisher DA, Pandian PR, Carlton E Autoimmune thyroid disease: An expanding spectrum. Pediatr Clin N Am 1987, 34:907.
86. Smyth PPA, McMullan NM, Grubek-Loebenstein B, O'Donovan DK Thyroid growth stimulating immunoglobulins in goitrous disease: Relationship to thyroid stimulating immunoglobulins. Acta Endocrinol 1986, 111:321.
87. Wadeleux PA, Winand RJ Thyroid growth modulating factors in the sera of patients with simple non-toxic goiter. Acta Endocrinol 1986, 112:502.
88. Guimaraes VC Subacute and Reidel's thyroiditis. Endocrinology 2006, 2069-2080. Lippincott Williams & Wilkins, Philadelphia. Fifth edition. L.J. DeGroot, J.L. Jameson (Eds.).
89. Volpé R Subacute thyroiditis. Pediatric thyroidology 1985, 252-264. Karger, Basel. F. Delange, D.A. Fisher, P. Malvaux (Eds.).
90. Farwell AP Infectious thyroiditis. The thyroid: A fundamental and clinical text 2005, 536-547. Lippincott Williams & Williams, Philadelphia. Ninth edition. L.E. Braverman, R.D. Utiger (Eds.).
91. Miyauchi A, Matsuzuka F, Kuma K, Takai S Pyriform sinus fistula: an underlying abnormality common in patients with acute suppurative thyroiditis. World J Surg 1990, 14:400.
92. Musharrafieh UM, Nassar NT, Azar ST Acute suppunative thyroiditis: A forgotten entity, Case report and literature review. The Endocrinologist 2002, 12:173.
93. Rauhofer U, Prager G, Hosmann M, et al. Cystic echinococcosis of the thyroid gland in children and adults. Thyroid 2003, 13:497.
94. Auram AM, Sturm CA, Michael CW, et al. Cryptococcal thyroiditis and hyperthyroidism. Thyroid 2004, 14:471.
95. McLanghlin SA, Smith SL, Meek SE Acute suppurative thyroiditis caused by pasteurella multocida and associated with thyrotoxicosis. Thyroid 2006, 16:307.
96. Davies TS Pathogenesis of Graves' disease. The thyroid: A fundamental and clinical text 2005, 457-473. Lippincott William & Wilkins, Philadelphia. Ninth edition. L.E. Braverman, R.D. Utiger (Eds.).
97. Gianoukakis AG, Douglas RS, King CS, et al. Immunoglobulin G from patients with Graves' disease induces interleukin-16 and RANTES expression in cultured human thyrocytes: A putative mechanism for T-cell infiltration of the thyroid in autoimmune disease. Endocrinology 2006, 147:1941.
98. Zimmerman D, Hayles AB Hyperthyroidism in children. Pediatric thyroidology 1985, 223. Karger, Basel. F. Delange, D.A. Fisher, P. Malvaux (Eds.).
99. Segni M, Leonardi E, Mazzaoncini B, et al. Special features of Graves' disease in early childhood. Thyroid 1999, 9:881.
100. Perrild H, Grüters-Kieslich A, Feldt-Rasmussen U, et al. Diagnosis and treatment of thyrotoxicosis in childhood: A European quentionnaire study. Eur J Endocrinol 1994, 131:467.
101. Shulman DI, Muhar I, Jorgensen EV, et al. Autoimmune hyperthyroidism in prepubertal children and adolescents: Comparison of clinical and biochemical features at diagnosis and response to medical therapy. Thyroid 1997, 7:755.
102. Hamburger JL Management of hyperthyroidism in children and adolescents. J Clin Endocrinol Metab 1985, 60:1019.
103. Rivkees SA, Sklar C, Freemark M The management of Graves' disease in children with special emphasis on radioiodine treatment. J Clin Endocrinol Metab 1998, 83:3767.
104. Read CH, Tansey MJ, Menda Y A 36 year retrospective analysis of the efficacy and safety of radioactive iodine in treating young Graves' patients. J Clin Endocrinol Metab 2004, 89:4229.
105. Rivkees S Radioactive iodine use in childhood Graves' disease: Time to wake up and smell the I-131. J Clin Endocrinol Metab 2004, 89:4227.
106. Marchant B, Lees JFH, Alexander WD Antithyroid drugs. The thyroid: Physiology and treatment of disease 1979, 209-252. Pergamon Press, Oxford. J.M. Hershman, G.A. Bray (Eds.).
107. Shen DC, Wu SY, Chopra IJ, et al. Long term treatment of Graves' hyperthyroidism with sodium ipodate. J Clin Endocrinol Metab 1985, 61:723.
108. Wu SY, Shyh TP, Chopra IJ, et al. Comparison of sodium ipodate (Oragrafin) and propylthiouracil in early treatment of hyperthyroidism. J Clin Endocinol Metab 1982, 54:630.
109. Bal CS, Kumar A, Chandra P Effect of Iopanoic acid on radioiodine therapy of hyperthyroidism: Long term outcome of a randomized control study. J Clin Endocrinol Metab 2005, 90:6536.
110. Glaser NS, Styne DM Predictors of early remission of hyperthyroidism in children. J Clin Endocrinol Metab 1997, 82:1719.
111. Tolis G, Bird C, Bertrand G, et al. Pituitary hyperthyroidism: Case report and review of the literature. Am J Med 1978, 64:177.
112. Beck Peccoz P, Persani L Thyrotropin-induced thyrotoxicosis. The thyroid: A fundamental and clinical text 2005, 500-507. Lippincott Williams & Wilkins, Philadelphia. Ninth edition. L.E. Braverman, R.D. Utiger (Eds.).
113. Shigakazu S, Nakamura H, Tagami T, et al. Pituitary resistance to thyroid hormone associated with a base mutation in the hormone binding domain of the human 3,5,3' triiodothyronine receptor b. J Clin Endocrinol Metab 1993, 76:1254.
114. Mixson AJ, Renault JC, Ransom S, et al. Identification of a novel mutation in the gene encoding the b-triiodothyronine receptor in a patient with apparent selective pituitary resistance to thyroid hormone. Clin Endocrinol 1993, 38:227.
115. Rosler A, Litvin Y, Hoge C, et al. Familial hyperthyroidism due to inappropriate thyrotropin secretion successfully treated with triiodothyronine. J Clin Endocrinol Metab 1982, 54:76.
116. Beck Peccoz P, Piscitelli G, Cattaneo MG, et al. Successful treatment of hyperthyroidism due to non-neoplastic pituitary TSH secretion with 2,5,3'-triiodothyroacetic acid (TRIAC). J Endocrinol Invest 1983, 6:217.
117. Abe K, Konno M, Sato T, Matsuura N Hyperfunctioning thyroid nodules in children. Am J Dis Child 1980, 134:961.
118. Osburne RC, Goren EN, Bybee DE, Johnsonbaugh RE Autonomous thyroid nodules in adolescents: Clinical characteristics and results of TRH testing. J Pediatr 1982, 100:383.
119. Kaplan MM Clinical evaluation and management of solitary thyroid nodules. The thyroid: A fundamental and clinical text 2005, 996-1010. Lippincott Williams & Wilkins, Philadelphia. Ninth edition. L.E. Braverman, R.D. Utiger (Eds.).
120. Kopp P, Muirhead S, Jourdain N, et al. Congenital hyperthyroidism caused by a solitary toxic adenoma harboring a novel somatic mutation (serene 281-isoleucine) in the extracellular domain of the thyrotropin receptor. J Clin Invest 1997, 100:1634.
121. Duprez L, Parma J, Van Sande J, et al. TSH receptor mutations and thyroid disease. Trends in Endocrinol 1998, 9:133.
122. Grueters A, Schonberg T, Bieberman H, et al. Severe congenital hyperthyroidism caused by a germline neomutation in the extracellular portion of the thyrotropin receptor. J Clin Endocrinol Metab 1998, 83:1431.
123. Vassart G Thyroid stimulating hormone receptor mutations. Endocrinology 2006, 2191-2200. Elsevier-Saunders, Philadelphia. Fifth edition. L.J. DeGroot, J.L. Jameson (Eds.).
124. Weinstein LS, Shenker A, Gejman PV, et al. Activating mutations of the stimulating G protein in the McCune Albright syndrome. N Engl J Med 1991, 325:1688.
125. Pacini F, DeGroot LJ Thyroid neoplasia. Endocrinology 2006, 2147-2180. Elsevier-Saunders, Philadelphia. Fifth edition. L.J. DeGroot, J.L. Jameson (Eds.).
126. Schlumberger MJ Papillary and follicular thyroid carcinoma. N Engl J Med 1998, 338:297.
127. Hung W Solitary thyroid nodules in 93 children and adolescents. Horm Res 1999, 52:15.
128. Hung W, Sarlis N Current controversies in the management of pediatric patients with well differentiated, nonmedullary cancer: A review. Thyroid 2002, 8:683.
129. Bauer AJ, Tuttle RM, Francis GL Differentiated thyroid carcinoma of children and adolescents. The Endocrinologist 2002, 12:135.
130. Raab SS, Silverman JF, Elsheikh TM, et al. Pediatric thyroid nodules: Disease demographics and clinical management as determined by fine needle aspiration biopsy. Pediatrics 1995, 95:46.
131. Mechanick JI Thyroid cancer in the pediatric patient. Malignant tumors of the thyroid 1992, 45-64. Springer Verlag, New York. R.H. Cobin, D.K. Sirota (Eds.).
132. Lam KY, Lo CY, Kwong DLW, et al. Malignant lymphoma of the thyroid. Am J Clin Pathol 1999, 112:263.
133. Shore RE, Hildreth N, Dvoretsky P, et al. Thyroid cancer among persons given x-ray treatment in infancy for an enlarged thymus gland. Am J Epidemiol 1993, 137:1068.
134. Winship T, Rosvoll RV Thyroid carcinoma in children: Final report and 20 year study. Clin Proc Child Hosp (Washington, DC) 1970, 26:327.
135. Robbins J, Schneider AB Radioiodine induced thyroid cancer: Studies in the aftermath of the accident at chernobyl. Trends in Metabolism 1998, 3:87.
136. Astakhova LN, Asnpaugh LR, Beebe GW, et al. Chernobyl-related thyroid cancer in children of Belarus: A case-control study. Radiation Res 1998, 150:349.
137. Khurana KK, Labrador E, Izquierdo R, et al. The role of fine needle aspiration biopsy in the management of thyroid nodules in children adolescents and young adults: A multi-institutional study. Thyroid 1999, 9:383.
138. Learoyd DL, Twigg SM, Zedenius JV, Robinson BG The molecular genetics of endocrine tumors. J Ped Endocrinol Metab 1998, 11:195.
139. Fenton CL, Lukes Y, Nicholson D, et al. The RET/PTC mutations are common in sporadic papillary thyroid carcinoma of children and young adults. J Clin Endocrinol Metab 2000, 85:1170.
140. Motomura T, Nikiforov YE, Namka H, et al. RET proto-oncogene in Japanese pediatric and adult papillary thyroid cancers. Thyroid 1998, 8:485.
141. Klugbauer S, Rabes HM The transcription coactivator HTIF-1 and a related protein are fused to the RET receptor tyrosine kinase in childhood papillary thyroid carcinomas. Oncogene 1999, 18:4388.
142. Pisarchik AV, Ermak G, Fornicheva V, et al. The RET/PTCI rearrangement is a common feature of chernobyl-associated papillary thyroid carcinomas from Belarus. Thyroid 1998 1998, 8:133.
143. Suchy B, Waldmann V, Klughauer S, Rabes HM Absence of RAS and p53 mutations in thyroid carcinomas of children after chernobyl in contrast to adult thyroid tumors. Brit J Cancer 1998, 11:195.
144. Xing M, Westra WH, Tufano RP, et al. BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer. J Clin Endocrinol Metab 2005, 90:6373.
145. Penko K, Livezey J, Fenton C, et al. BRAF mutations are uncommon in papillary thyroid cancer of young patients. Thyroid 2005, 4:320.
146. Weber F, Shen L, Aldred MA, et al. Genetic classification of benign and malignant thyroid follicular neoplasia based on a three gene combination. J Clin Endocrinol Metab 2005, 90:2512.
147. Eszlinger M, Wiench M, Jarzab B, et al. Meta and reanalysis of gene expression profiles of hot and cold thyroid nodules and papillary thyroid carcinoma for gene chips. J Clin Endocrinol Metab 2006, 91:1934.
148. Chi DD, Moley JE Medullary thyroid carcinoma. Surg Oncol Clin N Amer 1998, 7:681.
149. Learoyd DL, Lim LC, Robinson BG Medullary thyroid carcinoma. Endocrinology 2006, 2181-2190. Elsevier-Saunders, Philadelphia. Fifth edition. L.J. DeGroot, J.L. Jameson (Eds.).
150. Marsh DJ, Mulligan LM, Eng C RET proto-oncogene mutations in multiple endocrine neoplasia type 2 and medullary thyroid carcinoma. Horm Res 1997, 47:168.
151. Kouvaraki MA, Shapiro SE, Perrier NO, et al. RET proto-oncogene: A review and update of genotype-phenotype correlations in hereditary medullary thyroid cancer and associated endocrine tumors. Thyroid 2005, 15:531.
152. Iler MA, King DR, Ginn-Pease ME, et al. Multiple endocrine neoplasia, type 2A: A 25 year review. J Pediatr Surg 1999, 34:92.
153. Dvorakova S, Vaclavikova E, Sykorova V, et al. New multiple somatic mutations in the RET proto-oncogene associated with a sporadic medullary thyroid carcinoma. Thyroid 2006, 16:311.
154. Rave F, Kraimps JL, Dralle H, et al. Primary hyperparathyroidism in multiple endocrine neoplasia type 2A. J Intern Med 1995, 238:369.
155. Kloos RT, Mazzaferri EL A single recombinant human thyrotropin-stimulated serum thyroglobulin measurement predicts differentiated thyroid carcinoma metastases three to five years later. J Clin Endocrinol Metab 2005, 90:5047.
156. Kaplan EL Surgery of the thyroid. Endocrinology 2005, 2239-2260. WB Saunders, Philadelphia. Fifth edition. L.J. DeGroot, J.L. Jameson (Eds.).
157. Fisher DA A short history of pediatric endocrinology in North America. Pediatr Res 2004, 55:716.
158. Wilson JD Prospects for research for disorders of the endocrine system. JAMA 2004, 285:624.
159. Smith CL, Nawaz Z, O'Malley BW Coactivator and correpressor regulation of the agonist/antagonist activity of the mixed antiestrogen, 4-hydroxytamoxifen. Mol Endocrinol 1997, 11:657.
160. McKenna NJ, Xu J, Nawaz Z, et al. Nuclear receptor coactivators: Multiple enzymes, multiple complexes, multiple functions. J Steroid Biochem Mol Biol 1999, 69:3.
161. Baxter JD, Dillmann WH, Wes BL, et al. Selective modulation of thyroid hormone receptor action. J Steroid Biochem Mol Biol 2001, 76:31.
162. Miner JN, Chang W, Chapman MS, et al. An orally active selective androgen receptor modulator is efficacious on bone, muscle, and sex function with reduced impact on prostate. Endocrinology 2007, 148:363.